Phase Ib study of PRT543, an oral protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced splicing factor-mutant myeloid malignancies

Overview of attention for article published in Leukemia, January 2025

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

wikipedia: 1 Wikipedia page

Readers on

mendeley: 10 Mendeley

So far, Altmetric has seen 1 Wikipedia article.

PRT543

Cited by user Meodipt on 04 Mar 2025

PRT543 is an experimental anticancer drug which acts as an inhibitor of the enzyme protein arginine methyltransferase 5.

This page shows the most recent Wikipedia articles that mention this research output. Click here to find out how to access more activity.